glp-1 type 1 diabetes GLP-1R and GLP-1 Receptor Agonists as Treatments
Description
By integrating current evidence from clinical trials and meta-analyses, the review highlights how GLP-1RAs not only enhance glycemic control but also reduce blood pressure, induce weight loss, and mitigate inflammatory responses
Step 1: Check the medication
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Take two tablets once daily with a meal
that rapid weight loss may affect bone density, especially in populations already vulnerable to bone loss
